Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100045764Phase 4Recruiting
Phase 4, randomised, double-blind trial of ciprofol in None (2 arms), sponsored by Shanghai Fengxian District Central Hospital. Primary endpoint: Sedation/anesthesia time. Started May 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100045764.